Patent Assignment
Reel/Frame 067405/0368
Release of Security Interest
Recorded: 2024-05-14
Pages: 6
Assignor
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), AS COLLATERAL AGENT
Executed: 2024-05-13
Assignee
DRACEN PHARMACEUTICALS, INC.
300 INTERPACE PARKWAY, THE GRAND 1, BUILDING C3, PARSIPPANY, NEW YORK, 07054
Covered Property
(1)
NRF2 Protein Degraders
Application:
63/355,834 →
PCT:
PCT/US2023/069147 ↗
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 21, 2023
From: MUNROE, JOHN EDWIN; WILD, ROBERT CHRISTIAN
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 064014/0797 →
Security Interest
Jul 12, 2023
From: DRACEN PHARMACEUTICALS, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), AS COLLATERAL AGENT
Reel/Frame 064232/0765 →
Assignment of Assignor's Interest
Jul 13, 2023
From: MUNROE, JOHN EDWIN; WILD, ROBERT CHRISTIAN
To: DRACEN PHARMACEUTICALS, INC.
Reel/Frame 064248/0460 →
Assignment of Assignor's Interest
Jul 10, 2024
From: DRACEN PHARMACEUTICALS, INC.
To: GANYMEDE ONCOLOGY, INC.
Reel/Frame 067951/0276 →